Celldex Therapeutics to Present at Upcoming Investor Conferences
Celldex Therapeutics (NASDAQ:CLDX) has announced its management's upcoming participation in two major healthcare investor conferences. The company will engage in fireside chats at the Guggenheim Healthcare Innovation Conference on November 12th at 4:00 p.m. ET and the 7th Annual Evercore HealthCONx Conference on December 3rd at 4:15 p.m. ET. Both presentations will be available via live webcasts on the company's website under the 'Events & Presentations' section, with replays accessible for 90 days after each event.
Celldex Therapeutics (NASDAQ:CLDX) ha annunciato la prossima partecipazione del suo management a due importanti conferenze per investitori nel settore sanitario. L'azienda parteciperà a discussioni informali durante il Guggenheim Healthcare Innovation Conference il 12 novembre alle 16:00 ET e al 7th Annual Evercore HealthCONx Conference il 3 dicembre alle 16:15 ET. Entrambe le presentazioni saranno disponibili tramite webcast dal vivo sul sito web dell'azienda nella sezione 'Eventi e Presentazioni', con repliche accessibili per 90 giorni dopo ciascun evento.
Celldex Therapeutics (NASDAQ:CLDX) ha anunciado la próxima participación de su administración en dos importantes conferencias para inversionistas en el sector de la salud. La compañía participará en charlas informales en la Guggenheim Healthcare Innovation Conference el 12 de noviembre a las 4:00 p.m. ET y en la 7ª Conferencia Anual Evercore HealthCONx el 3 de diciembre a las 4:15 p.m. ET. Ambas presentaciones estarán disponibles a través de transmisiones en vivo en el sitio web de la empresa en la sección 'Eventos y Presentaciones', con repeticiones accesibles durante 90 días después de cada evento.
셀덱스 테라퓨틱스 (NASDAQ:CLDX)는 경영진이 두 개의 주요 헬스케어 투자자 컨퍼런스에 참여할 예정이라고 발표했습니다. 이 회사는 구게나임 헬스케어 혁신 컨퍼런스에 11월 12일 오후 4시 ET에 참여하고, 제7회 에버코어 헬스컨엑스 컨퍼런스에 12월 3일 오후 4시 15분 ET에 참여할 예정입니다. 두 프레젠테이션은 회사 웹사이트의 '이벤트 및 프레젠테이션' 섹션에서 라이브 웹캐스트를 통해 제공되며, 각 이벤트 후 90일 동안 재생할 수 있습니다.
Celldex Therapeutics (NASDAQ:CLDX) a annoncé la prochaine participation de sa direction à deux importantes conférences pour investisseurs dans le secteur de la santé. L'entreprise participera à des discussions informelles lors de la Guggenheim Healthcare Innovation Conference le 12 novembre à 16h00 ET et de la 7ème Conférence Annuelle Evercore HealthCONx le 3 décembre à 16h15 ET. Les deux présentations seront disponibles via des webcasts en direct sur le site web de l'entreprise dans la section 'Événements & Présentations', avec des rediffusions accessibles pendant 90 jours après chaque événement.
Celldex Therapeutics (NASDAQ:CLDX) hat die bevorstehende Teilnahme seines Managements an zwei wichtigen Investorenkonferenzen im Gesundheitswesen angekündigt. Das Unternehmen wird am 12. November um 16:00 Uhr ET an informellen Gesprächen auf der Guggenheim Healthcare Innovation Conference und am 3. Dezember um 16:15 Uhr ET auf der 7. jährlichen Evercore HealthCONx-Konferenz teilnehmen. Beide Präsentationen werden live über Webcasts auf der Website des Unternehmens im Bereich 'Veranstaltungen & Präsentationen' verfügbar sein, mit Nachübertragungen, die 90 Tage nach jeder Veranstaltung zugänglich sind.
- None.
- None.
HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:
Guggenheim Healthcare Innovation Conference on Tuesday, November 12th at 4:00 p.m. ET
7th Annual Evercore HealthCONx Conference on Tuesday, December 3rd at 4:15 p.m. ET
Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
FAQ
When is Celldex Therapeutics (CLDX) presenting at the Guggenheim Healthcare Conference in 2024?
What time is CLDX presenting at the Evercore HealthCONx Conference 2024?
How long will the CLDX conference presentation replays be available?
Where can I watch Celldex Therapeutics' (CLDX) investor conference presentations?
